ASX Share rice
Mon 28 Sep 2020 - 08:58:am (Sydney)

LCT Share Price

LIVING CELL TECHNOLOGIES LIMITEDLCTPharmaceuticals, Biotechnology & Life Sciences

LCT Company Information

Name:

Living Cell Technologies Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

330 Collins Street Melbourne VIC Australia 3000

Phone:

61 3 8689 9997

CEO & Exec. Director:

Dr. Kenneth Taylor

Chief Financial Officer:

Mr. Daya Uka

Chief Operating Officer:

Dr. Janice Lam

Company Sec.:

Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA

Company Overview:

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. The company's lead product is NTCELL, an alginate coated capsule, which is in clinical trials for the treatment of Parkinson's disease. It also develops LP-003, a peptide drug that reduces caloric intake targeting obesity; and LC-002, a novel calcitonin gene-related peptide antagonist targeting migraine. Living Cell Technologies Limited has a research collaboration agreement with the University of Auckland to identify products that utilize patented novel peptide synthetic chemistry technology for the treatments for obesity and migraine. The company was founded in 1987 and is based in Melbourne, Australia.

LCT Share Price Information

Shares Issued:

571.44M

Market Capitalisation:

$9.14M

Revenue (TTM):

$553.69K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.006

Profit Margin:

-1.7491

Operating Margin (TTM):

$-4.25

Return On Assets (TTM):

$-0.32

Return On Equity (TTM):

$-0.28

Quarterly Revenue Growth (YOY):

-0.325

Gross Profit(TTM):

$553.69K

Diluted Earnings Per Share (TTM):

$-0.002

LCT CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$1.24M

Change To Liabilities:

$-1,353,564

Total Cashflow From Investing Activities:

$1.24M

Net Borrowings:

$-50,241

Net Income:

$-968,469

Total Cash From Operating Activities:

$-3,109,790

Other Cashflow From Investing Activities:

$1.24M

Capital Expenditures:

$0

LCT Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-1,345,390

Net Income:

$-968,470

Gross Profit:

$3.17K

Operating Income:

$-2,743,620

Income Tax Expense:

$-376,923

Total Revenue:

$553.69K

LCT Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$512.72K

Total Stockholder Equity:

$2.88M

Total Assets:

$3.39M

Common Stock:

$74.37M

Retained Earnings:

$-71,492,720

Cash:

$2.96M

Total Current Liabilities:

$311.12K

Property - Plant & Equipment:

$276.25K

Net Tangible Assets:

$2.88M

Long-Term Investments:

$42.04K

Total Current Assets:

$3.07M

Net Receivables:

$90.75K

Short-Term Investments:

$318.29K

Accounts Payable:

$103.84K

Short-Term Investments:

$318.29

Non Current Liabilities Total:

$201.60K

LCT Share Price History

LCT News

14 Mar, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
14 Jan, 2020
Ken Taylor became the CEO of Living Cell Technologies Limited (ASX:LCT) in 2014. This analysis aims first to contrast...
14 Nov, 2019
It's not possible to invest over long periods without making some bad investments. But really big losses can really...
30 Sep, 2019
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...